These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 967859)

  • 1. [Role of blood proteins in binding and inactivation of HINA].
    Dudchik GKh; bilyk MA
    Probl Tuberk; 1976; 3():52-5. PubMed ID: 967859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Content of active fraction of HINA in the blood of patients with pulmonary tuberculosis and infectious hepatitis during treatment with isoniazid].
    Bilyk MA; Dudchik GKh
    Probl Tuberk; 1976 Sep; (9):47-50. PubMed ID: 1013113
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh; Bilyk MA
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inactivation of tubazid and its influence on the effectiveness of antibacterial therapy of patients with pulmonary tuberculosis].
    Sumbatov GA; Ioffe RA; Poliakova SG
    Probl Tuberk; 1965; 43(8):23-8. PubMed ID: 5869065
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum levels of isoniazid in patients with tuberculosis (author's transl)].
    Meier N; Pierart O; Kuhn S; Zabala M; Woywood E; Abarca L; Cortés S
    Rev Med Chil; 1977 Jun; 105(6):390-2. PubMed ID: 897430
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of isoniazid pharmacokinetics in the blood of patients with pulmonary tuberculosis with concomitant chronic Trematode infections].
    Korablev VN
    Antibiot Khimioter; 1990 Jun; 35(6):45-6. PubMed ID: 2400295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacokinetics of isoniazid in children (author's transl)].
    Advenier C; Saint-Aubin A; Scheinmann P; Paupe J
    Rev Fr Mal Respir; 1981; 9(5):365-74. PubMed ID: 7323401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
    Tipp ZI
    Probl Tuberk; 1969; 47(8):76-9. PubMed ID: 4987468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoniazid inactivation status and the development of chronic tuberculosis.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(3):227-34. PubMed ID: 5195905
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma concentrations of isoniazid in children with tuberculous infections.
    Olson WA; Pruitt AW; Dayton PG
    Pediatrics; 1981 Jun; 67(6):876-8. PubMed ID: 7232051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbiologic method of separate determination of protein-bound and non-protein-bound active INH fraction in the blood of tuberculosis patients during treatment with isoniazid].
    Bilyk MA; Dudchik GKh
    Lab Delo; 1977; (11):669-71. PubMed ID: 74442
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inactivation of the HINA preparations and certain indicators of the detoxicating function of the liver in patients with pulmonary tuberculosis].
    Fitsaĭ AV
    Probl Tuberk; 1973; 51(6):83-4. PubMed ID: 4764137
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood bacteriostatic activity in patients depending on the type of inactivation of isonicotinic acid hydrazide in the body].
    Gil'madinova RSh; Bakanova DIa
    Antibiotiki; 1971 Jan; 16(1):87-90. PubMed ID: 4994900
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of inactivation of phthivazid in the therapy of tuberculosis in children].
    Aminov NR
    Probl Tuberk; 1965; 43(8):29-33. PubMed ID: 5296614
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Gynecomastia caused by isoniazid. Value of determination of the inactivation phenotype].
    Bergogne-Berezin E; Nouhouayi A; Letonturier P; Thibault B; Tourneur R
    Nouv Presse Med; 1976 Jan; 5(4):213-4. PubMed ID: 1264675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of isoniazid concentration in the blood by polarofraphic method].
    Ershov AE; Sushkin AP; Guseva TM
    Probl Tuberk; 1975; (1):65-8. PubMed ID: 1144372
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
    Karkishchenko NN; Khoron'ko VV; Vorob'ev VS; Anisimova NB; Chubarian VT
    Probl Tuberk; 1987; (9):31-4. PubMed ID: 3422964
    [No Abstract]   [Full Text] [Related]  

  • 20. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.